Kamar N - Search Results

1

Malignancies in hepatitis C virus-positive and -negative kidney transplant recipients: A case-controlled study.

Dörr G, Del Bello A, Abravanel F, Marion O, Cointault O, Ribes D, Lavayssière L, Esposito L, Nogier MB, Hebral AL, Sauné K, Izopet J, Kamar N. Dörr G, et al. Among authors: kamar n. Transpl Infect Dis. 2017 Aug;19(4). doi: 10.1111/tid.12725. Epub 2017 Jun 26. Transpl Infect Dis. 2017. PMID: 28509330

2

Reversible posterior leukoencephalopathy syndrome in hepatitis C virus-positive long-term hemodialysis patients.

Kamar N, Kany M, Bories P, Ribes D, Izopet J, Durand D, Rostaing L. Kamar N, et al. Am J Kidney Dis. 2001 Apr;37(4):E29. doi: 10.1016/s0272-6386(01)90015-0. Am J Kidney Dis. 2001. PMID: 11273899

3

Evolution of hepatitis C virus quasispecies in renal transplant patients with de novo glomerulonephritis.

Kamar N, Rostaing L, Boulestin A, Sandres K, Dubois M, Ribes D, Modesto A, Durand D, Izopet J. Kamar N, et al. J Med Virol. 2003 Apr;69(4):482-8. doi: 10.1002/jmv.10335. J Med Virol. 2003. PMID: 12601755

4

[Is there a place for ribavirin in the treatment for renal transplant patients infected by hepatitis C virus?].

Kamar N, Sandres-Saune K, Selves J, Durand D, Izopet J, Rostaing L. Kamar N, et al. Nephrologie. 2003;24(2):89-94. Nephrologie. 2003. PMID: 12723514 French.

5

[Hepatitis C infection among patients receiving hemodialysis].

Kamar N, Izopet J, Rostaing L. Kamar N, et al. Nephrologie. 2003;24(3):133-41. Nephrologie. 2003. PMID: 12814060 Review. French.

6

Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histology.

Kamar N, Sandres-Saune K, Selves J, Ribes D, Cointault O, Durand D, Izopet J, Rostaing L. Kamar N, et al. Am J Kidney Dis. 2003 Jul;42(1):184-92. doi: 10.1016/s0272-6386(03)00422-0. Am J Kidney Dis. 2003. PMID: 12830471 Clinical Trial.

7

Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation.

Kamar N, Toupance O, Buchler M, Sandres-Saune K, Izopet J, Durand D, Rostaing L. Kamar N, et al. J Am Soc Nephrol. 2003 Aug;14(8):2092-8. doi: 10.1097/01.asn.0000079613.81511.3c. J Am Soc Nephrol. 2003. PMID: 12874463

8

Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions.

Cointault O, Kamar N, Bories P, Lavayssiere L, Angles O, Rostaing L, Genestal M, Durand D. Cointault O, et al. Among authors: kamar n. Nephrol Dial Transplant. 2004 Jan;19(1):171-8. doi: 10.1093/ndt/gfg488. Nephrol Dial Transplant. 2004. PMID: 14671053

9

Ribavirin pharmacokinetics in renal and liver transplant patients: evidence that it depends on renal function.

Kamar N, Chatelut E, Manolis E, Lafont T, Izopet J, Rostaing L. Kamar N, et al. Am J Kidney Dis. 2004 Jan;43(1):140-6. doi: 10.1053/j.ajkd.2003.09.019. Am J Kidney Dis. 2004. PMID: 14712437

10

[Hepatitis C virus infection in renal-transplant patients].

Kamar N, Izopet J, Ribes D, Rostaing L. Kamar N, et al. Nephrologie. 2004;25(1):9-15. Nephrologie. 2004. PMID: 15022868 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

756 results

Search Page

Filters